Old Web
English
Sign In
Acemap
>
authorDetail
>
Ólöf Thórisdóttir
Ólöf Thórisdóttir
Novo Nordisk
Endocrinology
Diabetes mellitus
Internal medicine
Insulin
Type 2 diabetes
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
1034-P: Efficacy and Safety of Fast-Acting Insulin Aspart According to Baseline HbA1c in Adults with Type 2 Diabetes Treated with a Basal-Bolus Regimen
2020
Diabetes
Edward Franek
Magnus Ekelund
Ólöf Thórisdóttir
Hak Chul Jang
Katarina Lalic
Naveen Rathor
Ludger Rose
Alfonso Soto González
Robert J. Silver
Wendy Lane
Show All
Source
Cite
Save
Citations (0)
1037-P: Efficacy and Safety of Fast-Acting Insulin Aspart in Adults with T2D with Different Insulin Requirements
2020
Diabetes
Wendy Lane
Magnus Ekelund
Ólöf Thórisdóttir
Esteban Jódar
Alejandra Oviedo
Naveen Rathor
Peter A. Senior
Giorgio Sesti
Edward Franek
Show All
Source
Cite
Save
Citations (0)
A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2)
2018
European Journal of Pediatrics
Mark D. Wheeler
Margarita Barrientos-Pérez
Fu-Sung Lo
Bo Liang
Alison Lunsford
Ólöf Thórisdóttir
Nehama Zuckerman Levin
Show All
Source
Cite
Save
Citations (3)
1